KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - AccuredRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arbutus Biopharma (ABUS) Treasury Shares (2023)

Arbutus Biopharma (ABUS) has disclosed Treasury Shares for 1 consecutive years, with $1.2 million as the latest value for Q4 2023.

  • Quarterly Treasury Shares changed N/A to $1.2 million in Q4 2023 from the year-ago period, while the trailing twelve-month figure was $1.2 million through Dec 2023, changed N/A year-over-year, with the annual reading at $1.2 million for FY2023, N/A changed from the prior year.
  • Treasury Shares hit $1.2 million in Q4 2023 for Arbutus Biopharma.
  • In the past five years, Treasury Shares ranged from a high of $1.2 million in Q4 2023 to a low of $1.2 million in Q4 2023.